Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Of Novel Combination Of Maraviroc + Atazanavir/Ritonavir vs. Atazanavir/Ritonavir + Emtricitabine/Tenofovir For The Treatment Of Naïve HIV-Infected Patients With R5 HIV-1

NCT00827112 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00827112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Of Novel Combination Of Maraviroc + Atazanavir/Ritonavir vs. Atazanavir/Ritonavir + Emtricitabine/Tenofovir For The Treatment Of Naïve HIV-Infected Patients With R5 HIV-1
Lead sponsor
ViiV Healthcare
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2011
Enrollment
129 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus-1